Ke Xiangyu, Lin Zhirui, Ye Zebing, Leng Meifang, Chen Bo, Jiang Chunjie, Jiang Xiaoyun, Li Guowei
Centre of Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Department of Cardiology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Front Endocrinol (Lausanne). 2021 Jul 22;12:679655. doi: 10.3389/fendo.2021.679655. eCollection 2021.
The global burden of diabetes mellitus and its complications are currently increasing. Diabetic cardiomyopathy (DCM) is the main cause of diabetes mellitus associated morbidity and mortality; therefore, a comprehensive understanding of DCM development is required for more effective treatment. A disorder of epigenetic posttranscriptional modification of histones in chromatin has been reported to be associated with the pathology of DCM. Recent studies have implicated that histone deacetylases could regulate cardiovascular and metabolic diseases in cellular processes including cardiac fibrosis, hypertrophy, oxidative stress and inflammation. Therefore in this review, we summarized the roles of histone deacetylases in the pathogenesis of DCM, aiming to provide insights into exploring potential preventative and therapeutic strategies of DCM.
目前,糖尿病及其并发症的全球负担正在增加。糖尿病性心肌病(DCM)是糖尿病相关发病和死亡的主要原因;因此,为了更有效地治疗,需要全面了解DCM的发展过程。据报道,染色质中组蛋白的表观遗传转录后修饰紊乱与DCM的病理相关。最近的研究表明,组蛋白脱乙酰酶可以在包括心脏纤维化、肥大、氧化应激和炎症在内的细胞过程中调节心血管和代谢疾病。因此,在本综述中,我们总结了组蛋白脱乙酰酶在DCM发病机制中的作用,旨在为探索DCM的潜在预防和治疗策略提供见解。